6 hasil untuk "Burak Okyar"
Menampilkan 1–6 · 0,00 detik · RSS
-
Artikel Jurnal
Combination csDMARD and Infliximab in Primary Hypertrophic Osteoarthropathy, a Case-Based Review
An 18-year-old male patient presented with excessive sweating on the palms of the hands and soles of the feet. X-ray showed periostosis in the carpal and tarsal bones. Genetic analysis revealed c.1807C>T(p.Arg603Ter), a homozygous mutation, and PHO was diagnosed. The patient was treated with…
-
Artikel Jurnal
ADDING NINTEDANIB TO IMMUNOSUPPRESSIVE THERAPY IN CONNECTIVE TISSUE RELATED INTERSTITIAL LUNG DISEASES; CASE SERIES BASED ON REAL-LIFE DATA FROM A SINGLE CENTRE
Connective tissue-related interstitial lung disease (CTD-ILD) is a severe process that progresses in approximately 30% of patients. These patients may need aggressive treatment. Therefore, new treatment strategies are being developed. Anti-fibrotic agents used in idiopathic pulmonary fibrosis are…
-
Artikel Jurnal
Evaluation of remission in patients with radiographic axial spondyloarthritis using an ultrasonography-based enthesitis score: a cross-sectional study
Introduction This study aimed to evaluate ultrasonographic entheseal abnormalities in patients with radiographic axial spondyloarthritis (r-axSpA) who were in clinical remission for at least 6 months and receiving either nonsteroidal anti-inflammatory drugs (NSAIDs) or biologic agents. Material and…
-
Artikel Jurnal
The correlation between serum YKL-40, proteinuria and inflammation in patients with systemic lupus erythematosus
Aim: YKL-40 is a protein associated with acute and chronic inflammation and cancer. Neutrophils, macrophages, and cancer cells normally produce it. It plays a role in cell proliferation, differentiation, angiogenesis, inflammation, and extracellular matrix remodeling. It is also a marker of…
-
Artikel Jurnal
COVID-19 vaccination in patients on biologic or targeted-synthetic disease modifying anti-rheumatic drug therapy: A multi center real-world data
Objective: To assess the effectiveness of COVID-19 vaccination in patients with rheumatic diseases undergoing biologic (bDMARDs) or targeted-synthetic disease-modifying anti-rheumatic drugs (tsDMARDs). Methods: This cross-sectional study was conducted at ten rheumatology clinics in Turkey between…
-
Artikel Jurnal
Clinical spectrum and outcomes of mononeuritis multiplex in rheumatic diseases: evidence from a nationwide multicenter study
Background: Mononeuritis multiplex (MM) is a severe and clinically heterogeneous form of peripheral neuropathy, most commonly arising in the context of systemic vasculitis in rheumatology practice. Despite its potential to cause substantial functional impairment, data on its clinical spectrum…